About
As a clinical pharmacist, Nathan's top priority is the delivery of safe and effective medication therapy to patients. In partnership with the Lurie Children's Precision Medicine Initiative, Nathan developed the Pharmacogenomics Program in 2020. Pharmacogenomics is the study of the relationship between genetic variability and drug disposition, response, and toxicity. Precision Pharmacotherapy combines pharmacogenomics and precision medicine to customize medication therapy based on a patient’s genetics, environment, and lifestyle. Precision Pharmacotherapy has the potential to improve medication outcomes, decrease side effects, lower cost of treatment, and improve patient safety.
Program
Education & Training
Education: Doctor of Pharmacy, Drake University, 2008
Postgraduate Training: PGY1 Pharmacy Residency, VA Puget Sound Health Care System Medical Center, 2008-2009; PGY2 Pediatric Pharmacy Residency, Boston Children's Hospital, 2009-2010
Board Certifications: Pediatric Pharmacy Specialist
Professional Organizations: American Society of Healthsystem Pharmacists (ASHP), Pediatric Pharmacy Association (PPA), Clinical Pharmacogenetics Implementation Consortium (CPIC), Pharmacogenomics Global Research Network (PGRN)